Professional Documents
Culture Documents
Non Traumatic Emergent Neuroradiology
Non Traumatic Emergent Neuroradiology
LIFELONG LEARNING
FOR RADIOLOGY
QUESTION 3
QUESTION 1 What is the most definitive test for diagnosing
Which of the following is the preferred diagnosis? CNS vasculitis?
A. Arteriovenous malformation. A. CT angiography with 3D volume rendering.
B. Hypertensive hemorrhage. B. Cerebral angiography.
C. Hemorrhagic tumor or metastasis. C. Biopsy.
D. Vasculitis. D. MR angiography.
E. Amyloid angiopathy. E. Transcranial Doppler sonography.
A B D
Fig. 1—32-year-old man with headache and general fatigue who was diagnosed with viral syndrome and discharged but returned with severe headache and confusion.
A and B, Unenhanced CT (A) and CT angiography (B) of head were performed. Unenhanced CT shows large right frontal intraparenchymal hematoma and surrounding
edema (arrow, A), likely representing subacute intracranial hematoma. CT angiography does not reveal any cerebral aneurysms, arteriovenous malformation, or en-
hancing focus as possible cause of hematoma.
C and D, Cerebral angiography shows irregularity of small- to medium-sized vessels (arrows, D) and beaded appearance, consistent with vasculitis. Patient admitted
that he smokes marijuana almost daily and has long history of amphetamine use.
Solution to Question 1 gal infection, bacterial vasculitis, and HIV vasculitis. The fre-
Arteriovenous malformation (AVM) is not an unusual cause quent causes of noninfectious vasculitis are immune-mediated
of intracranial hematoma for the young patient in this case. vasculitis such as rheumatoid arthritis and systemic lupus er-
Patients with AVM often present with acute intracranial hem- ythematosus, and granulomatous disease, such as Wegener’s
orrhage or ischemic symptoms due to steal phenomenon. CT granulomatosis and sarcoid, as well as giant cell arteritis (also
angiography often reveals a tangle of markedly dilated arter- called temporal arteritis). Drugs, particularly amphetamines
ies and veins with a nidus of AVM. If the AVM is small, it may and cocaine, are frequent causes of noninfectious vasculitis.
not be visualized or diagnosed correctly with CT angiography. An amphetamine causes inflammatory vasculitis with vascu-
In this setting, cerebral angiography is the most definitive test. lar wall necrosis and subsequent hemorrhage. The pathologic
However, cerebral angiography in this patient did not show features of amphetamine-related vasculitis are similar to
early venous filling or an abnormal tangle of blood vessels to those of polyarteritis nodosa. This patient had taken amphet-
indicate AVM. Therefore, option A is not the best response. amines for several years. Cocaine, on the other hand, induces
Acute intracranial hematoma can have a number of causes. cerebral infarction or ischemia as well as hemorrhage by vaso-
The most common cause is hypertensive hemorrhage. Hy- constrictive effect and increased platelet aggregation, rather
pertensive hemorrhages, which originate from terminal small than a vasculitis-type inflammation of the vessels [1]. Options
vessels, are often centered at the basal ganglia, particularly A, B, C, and D are not the best responses.
the putamen and the external capsule; the thalamus; the Marfan syndrome is an autosomal dominant disorder of
pons; and occasionally, the cerebellum. Lobar hemorrhage the connective tissue characterized by disproportionally
can be seen in a setting of hypertension (≈ 1–2%), but it is long limbs and tall stature. It affects the heart and aorta
rare. Hypertensive hemorrhage is much more common in and causes aortic root dilatation, aortic regurgitation, and
older patients. Option B is not the correct response. dissection. However, involvement of CNS vessels is unusual.
Certain types of brain tumors are often associated with Option E is the best response.
intracranial hemorrhage. These are often aggressive tumors, Solution to Question 3
such as glioblastoma multiforme, or vascular tumors, such as Because many cases of vasculitis affect small to medium-
metastases from renal cell carcinoma or melanoma, but rare- sized blood vessels, MR angiography is relatively insensitive
ly papillary thyroid cancer and choriocarcinoma. Lung can- for the diagnosis of CNS vasculitis. CT angiography is less
cer and breast cancer are not considered vascular; however, accurate than cerebral angiography. Cerebral angiography is
the incidence of brain metastasis from lung and breast can- used as the gold standard for diagnosis at many institutions.
cers is exceedingly higher than that of other vascular can- When characteristic angiographic findings such as alternat-
cers. Thus, when all hemorrhagic brain metastases are re- ing areas of stenosis and dilatation or a beading appearance
viewed, lung and breast remain the two top primary choices. are observed in multiple vessels and multiple vascular beds,
Intracranial hemorrhage associated with brain tumor often cerebral angiography is diagnostic. However, angiography
has a focal area of enhancement and significant mass effect can be normal in up to 40% of biopsy-proven cases. Thus,
or vasogenic edema. Option C is not the best response. negative cerebral angiography does not completely exclude
Vasculitis is one of the causes of intracranial hemorrhage the diagnosis. Moreover, its specificity is not perfect. Intra-
and is more frequently seen in young patients. Vasculitis can cranial atherosclerotic disease may show irregularity of mul-
present with acute hemorrhage or ischemic symptoms. Many tiple vessels, mimicking CNS vasculitis.
causes of vasculitis affect small- to medium-sized vessels; Transcranial Doppler sonography is used to characterize
therefore, CT angiography may not show an irregularity of the morphology of the superficial temporal artery as a
the blood vessels as definitively as cerebral angiography. Cere- screening tool for temporal arteritis. However, transcranial
bral angiography in Figures 1C and 1D shows a classic ap- Doppler sonography is not suitable to evaluate arteries fully
pearance of segmental narrowing and poststenotic dilatation to diagnose CNS vasculitis. Options A, B, D, and E are not
involving multiple small- to medium-sized blood vessels, con- the best responses.
sistent with vasculitis. Option D is the best response. Biopsy of CNS tissue would logically be considered the
Amyloid angiopathy often causes a lobar intracranial ultimate gold standard of diagnosis, but clearly the proce-
hemorrhage centered at the deep white matter in the frontal dure is limited by several factors. It is highly invasive and
or parietal lobes. Amyloid angiopathy is much more common carries certain risks. Successful biopsy requires a willing
in elderly patients and is rare in young patients. Cerebral an- and experienced neurosurgeon, who may not be readily
giography may not show any irregularity or narrowing. Am- available. Sampling error could result in limited sensitivity.
yloid angiopathy is often diagnosed after excluding other The site of biopsy should be tailored to the individual pa-
causes in elderly patients. Option E is not the best response. tient [2]. The biopsy of the superficial temporal artery is
Solution to Question 2 often performed in patients suspected of having giant cell
The causes of vasculitis are often divided into infectious vasculitis. The false-negative rate of biopsy for a diagnosis
and noninfectious. Infectious causes include tuberculosis, fun- of vasculitis has been reported to be 16%, yielding a sensi-
tivity of 84% [2]. Therefore, the most definitive test is bi- posure, radiation, and malignancies. Cerebral angiography
opsy of the blood vessels. Option C is the best response. is more sensitive than noninvasive vascular imaging (CT an-
giography or MR angiography), but it is invasive and has
Conclusion limited sensitivity and specificity. Treatment of noninfec-
Vasculitis involving the CNS presents diagnostic chal- tious vasculitis is long-term, high-dose immunosuppression,
lenges to clinicians as well as radiologists. There are many which causes profound morbidity as a result of opportunis-
causes, including infection, autoimmune disease, drug ex- tic infection or organ failures.
obtained immediately after her admission (Figs. 2F and 2G) of an acute clot in the expected location of the proximal
and showed marked worsening of the cerebral edema and MCA (dense MCA sign). In this case, an area of low attenu-
diffuse effacement of the cortical sulci and basilar cistern. ation predominantly involved the white matter and spared
In addition, a new focus of venous infarction and parenchy- the gray matter. In addition, diffusion-weighted imaging
mal hemorrhage was present in the left frontal lobe. and the ADC map showed no area of restricted diffusion.
Option A is not the best response.
Solution to Question 4
In the inferior aspect of the superior sagittal sinus on ini-
tial head CT was an area of high attenuation with a convex QUESTION 6
border that was of concern for superior sagittal sinus throm-
Which one of the following is NOT associated
bosis. Contrast-enhanced head CT showed lack of contrast
with venous sinus thrombosis?
enhancement in the superior sagittal sinus, the empty delta
sign. Findings were consistent with venous sinus thrombo- A. Sickle cell disease.
sis and venous infarction involving the left temporal lobe. B. Oral contraceptives.
The patient had been taking oral contraceptives for the pre- C. Cancer.
vious 3 months. D. Disseminated intravascular coagulation.
CT findings of middle cerebral artery (MCA) infarction E. Dehydration.
are loss of gray and white matter differentiation or presence
C D E
Herpes encephalitis typically involves the medial tempo- thrombosis [3]. A subacute blood clot in the venous sinus is
ral lobe and is often associated with parenchymal hemor- often seen as hyperintense on T1-weighted images as a re-
rhage. This was the diagnosis made at the outside hospital, sult of methemoglobin mimicking flowing blood on time-of-
and the patient was treated with acyclovir. However, herpes flight (TOF) MR venography. Phase-contrast MR venogra-
encephalitis does not explain the presence of a clot in the phy is a fairly reliable test for the diagnosis of subacute
superior sagittal sinus. Option B is not the best response. venous sinus thrombosis.
The presence of tumor with vasogenic edema is also a Recently, rapid contrast-enhanced gradient-echo imag-
possibility based on the area of low attenuation in the left ing has been reported to yield a higher diagnostic accuracy
temporal lobe. However, this does not explain the presence than 2D TOF MR venography [4, 5]. With advances in
of a clot in the superior sagittal sinus. Option C is not the MDCT technology, CT angiography and venography have
best response. been increasingly used to diagnose venous sinus thrombo-
The correct diagnosis is venous sinus thrombosis and ve- sis and are considered a quick and reliable alternative to
nous infarction involving the left temporal lobe. Option D is MR venography. Options A, B, C, and E, the appropriate
the best response. The venous sinus can show slightly high next tests to confirm venous sinus thrombosis, are not the
attenuation, particularly among athletes, smokers, or neo- best responses.
nates. The lateral border of the venous sinus, in these normal Cerebral angiography also shows lack of flow in the dural
settings, should be concave, not convex toward the brain pa- venous sinuses. However, cerebral angiography is an inva-
renchyma. After the administration of contrast material, the sive test that is associated with complication rates of 1–2%.
dura may enhance but the venous sinus does not, giving the Noninvasive imaging should be considered first to confirm
empty delta sign. Venous sinus thrombosis can be a challeng- the diagnosis of venous sinus thrombosis. Option D, which
ing diagnosis to make unless one has a high clinical suspicion. is the least appropriate technique, is the best response.
Patients present with nonspecific headache or confusion, and
a clinical history of oral contraceptive use is often not avail- Solution to Question 6
able to radiologists at the time of interpretation. Common medical conditions associated with venous si-
Sagittal T1-weighted MR images at the outside hospital nus thrombosis are pregnancy, a postpartum state, and
showed lack of flow void along the superior sagittal sinus, hypercoagulable states such as sickle cell disease, oral con-
highly suggestive of the diagnosis. Please note that diffu- traceptives use, and cancer. Dehydration often seen in neo-
sion-weighted images and the ADC map did not necessar- nates and elderly patients is associated with venous sinus
ily show an area of restrictive diffusion in the setting of thrombosis as a result of low-flow circulatory states. Ex-
venous infarction because increased venous pressure ini- trinsic compression (tumor) or adjacent infection (mas-
tially causes vasogenic edema. This is distinctly different toiditis) is also a risk factor. Options A, B, C, and E are not
from arterial infarction, when the arterial supply to an the best responses.
area of the brain is abruptly terminated, resulting in cyto- Disseminated intravascular coagulation, however, is a
toxic edema. Lack of diffusion signal change should not hypocoagulable state and is not associated with venous si-
exclude venous infarction. However, venous infarction nus thrombosis. Option D is the best response.
does progress to cytotoxic edema with restricted diffusion Venous sinus thrombosis is an underdiagnosed condition
if the disease remains untreated. and can be a life-threatening disease if left untreated. Delay
in diagnosis often leads to rapid deterioration and poor clin-
Solution to Question 5 ical outcomes. Intracranial hemorrhage is associated with
The next diagnostic test to confirm venous sinus throm- 20–50% of cases of venous sinus thrombosis. Treatment for
bosis is brain MRI with MR venography. On conventional venous sinus thrombosis is immediate IV anticoagulation
MRI, venous sinus thrombosis may be suspected from lack with low-molecular-weight heparin, despite the risk of
of a flow void or high-signal thrombus in the dural sinuses. hemorrhagic complications [6].
Lack of flow void is best appreciated on FLAIR or T2-
weighted spin-echo images. Parenchymal changes, such as Conclusion
venous infarction or hemorrhage, along with lack of a flow Venous sinus thrombosis is an underdiagnosed condition
void on conventional MRI raises the suspicion of venous that can potentially lead to adverse clinical sequelae. Find-
sinus thrombosis. Superacute thrombus is relatively iso- ings on contrast-enhanced CT or conventional T1-weighted
intense on T1- and hypointense on T2-weighted images be- sagittal images should make one suspicious in the appropri-
cause of deoxyhemoglobin potentially mimicking slow ve- ate clinical setting. Understanding the risk factors and med-
nous flow on conventional MR images and thus requiring ical history of patients will help to guide further diagnostic
MR venography to confirm the diagnosis of venous sinus testing and immediate treatment.
A B C
Solution to Question 7
QUESTION 7 Arteriovenous malformation (AVM) is a congenital anom-
aly of blood vessels with one or more large feeding arteries
What is the most likely cause of the findings and drainage veins. AVM often presents not only with sub-
on unenhanced CT? arachnoid hemorrhage but also with parenchymal hemor-
A. Arteriovenous malformation rupture. rhage or symptoms of ischemia due to steal phenomenon.
B. Venous sinus thrombosis. Blood flow preferentially goes to AVMs with low resistance,
leaving the adjacent normal brain relatively hypoperfused.
C. Cerebral aneurysm rupture.
CT may show a hyperdense mass or curvilinear or speckled
D. Amyloid angiopathy.
calcification adjacent to a parenchymal hematoma. MRI
E. Hypertensive hemorrhage.
may show numerous foci of flow voids and venous aneurys-
mal dilatation. Option A is not the best response.
QUESTION 8
Venous sinus thrombosis could present with subarachnoid
What is the 30-day mortality rate of hemorrhage; however, it tends to be focal to the area of ve-
subarachnoid hemorrhage secondary to nous infarction or hypertension. Venous sinus thrombosis
aneurysm? does not normally present diffuse subarachnoid hemor-
rhage. Option B is not the best response.
A. 15%. Unenhanced CT of the head shows diffuse subarachnoid
B. 30%. hemorrhage as well as a focal hematoma along the anterior
C. 45%. falx, a typical location for a ruptured anterior communicating
D. 65%. artery aneurysm. Option C is the best response. Approximately
E. 80%. 50–70% of subarachnoid hemorrhages are due to aneurysm
rupture. Of patients with subarachnoid hemorrhage, 10–15%
QUESTION 9 have no aneurysm found even on cerebral angiography.
Amyloid angiopathy commonly affects elderly patients
Which of the following factors does NOT
and presents with a lobar rather than a subarachnoid hemor-
influence management decisions for a
rhage. Option D is not the best response. Hypertensive hem-
ruptured aneurysm?
orrhage often affects the small perforating vessels along the
A. Age. lenticulostriate or thalamoperforating vessels and thus is of-
B. Sex. ten present with parenchymal hemorrhage in the basal gan-
C. Aneurysm size. glia, thalamus, and pons. Option E is not the best response.
D. Aneurysm location.
E. History of hypertension. Solution to Question 8
Aneurysmal subarachnoid hemorrhage (SAH) has a
QUESTION 10 30-day mortality rate of 45%, with approximately half of
the survivors sustaining irreversible brain damage [7]. Option
Despite CT angiography showing an aneurysm C is the best response. The annual incidence of aneurysmal
causing subarachnoid hemorrhage, cerebral SAH is six per 100,000 in the United States. Approximately
angiography is still performed at some 5–10% of stroke cases are secondary to ruptured saccular
institutions. Which one of the following is aneurysms [8]. Recurrent hemorrhage remains a serious con-
NOT a rationale for performing cerebral sequence, with a 70% fatality rate in patients who rebleed.
angiography in this setting?
Solution to Question 9
A. Searching for an additional incidental aneurysm that Treatment options for a ruptured aneurysm are surgical
could be treated at the same time. resection or endovascular coil embolization. Endovascular oc-
B. Better assessing the degree of incorporation of the clusion of aneurysms using electrolytically detachable Gug-
aneurysm wall into the parent vessel. lielmi detachable coil system (GDC, Target Therapeutics [now
C. Assessing flow dynamics—that is, the side of the Boston Scientific]) has been used to treat ruptured or unrup-
internal carotid artery feeding anterior tured aneurysms in a large number of patients worldwide.
communicating aneurysm. Published reports suggest that the endovascular technique is
D. Measuring the aneurysm neck–dome ratio. associated with fewer treatment-related complications than
E. Suspecting mycotic aneurysm in patients with IV open surgery [7]. However, the long-term efficacy in the pre-
drug use. vention of rupture or recurrence of aneurysm remains in-
determinate. The recent International Subarachnoid Aneu-
rysm Trial (ISAT) showed that retreatment was performed small perforating vessels, the relationship of the aneurysm to
in 17.4% of patients treated with endovascular coiling and the parent vessels (how much of the aneurysm wall is incor-
in 3.8% of patients after surgical clipping [9]. Younger age porated into the parent vessel), and the flow dynamics of an-
and larger aneurysm size were risk factors for retreatment. eurysms that affect surgical planning. Multiple aneurysms
A higher rate of recurrence is seen in posterior communicat- can be seen in patients with subarachnoid hemorrhage. These
ing artery aneurysms after endovascular coiling and anterior incidental aneurysms are often smaller than 3 mm, which CT
communicating artery aneurysms after surgical clipping, angiography has a limited ability to detect. Small unrup-
which might reflect the technical difficulty. Hypertension is tured aneurysms are associated with a risk of future SAHs.
also associated with an increasing rate of rupture in patients If they are in a surgically or endovascularly accessible loca-
with an unruptured aneurysm. Thus age, medical history tion, these incidental aneurysms can be treated at the same
such as hypertension, aneurysm location, and size are all rel- time as the ruptured primary aneurysm. Mycotic aneurysms
evant factors in treatment decisions and, therefore, options often involve peripheral vessels and may present with sub-
A, C, D, and E, all relevant factors in treatment decisions, arachnoid or parenchymal hemorrhage or septic emboli. Be-
are not the best responses. Although aneurysms are more cause mycotic aneurysms involve distal vessels, cerebral angi-
common in women than in men, sex is not a factor affecting ography is a more definitive test than CT angiography.
management decisions or predicting outcomes. Option B is Options A, B, C, and E are not the best responses. The aneu-
the best response. rysm neck–dome ratio can be calculated on the basis of CT
angiography. Option D is the best response.
Solution to Question 10
CT angiography is a noninvasive vascular imaging tech- Conclusion
nique that has replaced catheter angiography in some insti- SAH associated with aneurysm rupture has high rates of
tutions. CT angiography may show aneurysms larger than 3 mortality and morbidity. Accurate detection and assess-
mm with a sensitivity of 77–97% and specificity of 87–100% ment of cerebral aneurysm lead to proper treatment deci-
[10]. CT angiography also has been used as a screening tool in sions by either surgical clipping or endovascular coiling.
populations at high risk for cerebral aneurysms. Cerebral an- Although CT angiography has rapidly replaced cerebral an-
giography, however, still remains the gold standard in the di- giography in some institutions, 3D rotational angiography
agnostic evaluation of cerebral aneurysms. In particular, 3D provides the most information regarding characterization
rotational angiography shows the most information about of aneurysms in relation to parent or adjacent vessels.
Scenario 4
Clinical History QUESTION 11
A 65-year-old woman presented to the emergency de-
partment 4 hours after the onset of right-sided weakness Assuming the patient does not have any
and dysarthria. Unenhanced CT of the head was obtained. medical conditions, what would be the most
Description of Images appropriate urgent therapy at this point?
Unenhanced CT of the head (Figs. 4A and 4B) showed A. IV recombinant tissue plasminogen activator (tPA).
loss of gray–white matter differentiation in the left insular B. IV streptokinase.
cortex and the temporal lobe. The left middle cerebral ar- C. IV heparin.
tery was hyperdense compared with the basilar artery. D. Antiplatelet therapy and aspirin.
The patient underwent cerebral angiography for poten- E. Intraarterial tPA and mechanical clot removal.
tial endovascular intervention. A left internal carotid artery
injection image (Fig. 4C) showed the presence of a clot in
the right internal carotid bifurcation and no flow visible in QUESTION 12
the anterior and middle cerebral arteries. The microcathe- What percentage of patients with acute
ter was placed proximal to the clot before advancing the ischemic stroke are treated with IV tPA?
Merci retrieval device (Merci Retrieval System, Concentric
Medical, Inc.) (Fig. 4D). Subsequent angiography showed A. Less than 6%.
persistent occlusion of the MCA branches (Fig. 4E). In- B. 8–15%.
traarterial tissue plasminogen activator (tPA) was infused C. 20–25%.
through the left MCA; after tPA infusion, angiography (Fig. D. 25–50%.
4F) showed opening of the anterior division of the left MCA E. 50–60%.
and occlusion of the posterior division of the left MCA.
Solution to Question 11
QUESTION 13 Current therapy for acute stroke is limited to IV recombi-
nant tPA administered within 3 hours of symptom onset. The
Which of the following is NOT associated with results of the National Institute of Neurologic Disorders and
poor neurologic outcomes in patients with Stroke (NINDS) tPA trial showed that the use of tPA within 3
acute ischemic infarction? hours of ischemic stroke onset substantially improved func-
tional outcomes compared with a placebo group at 3 months
A. Hypoventilation.
[11]. Based on this trial, for every 100 patients given tPA, 12
B. Extensive area of low attenuation and mass effect
more experienced complete neurologic recovery than patients
on initial head CT.
given a placebo. The European Corporative Acute Stroke
C. Hyperglycemia. (ECASS) randomized trial of tPA using a 6-hour therapeutic
D. Hypothermia. window did not show an overall benefit, primarily because of a
E. Arrhythmia. high rate of cerebral hemorrhage [12]. The current strict
A B C
D E F
Fig. 4—65-year-old woman 4 hours after onset of right-sided weakness and dysarthria who underwent cerebral angiography for potential endovascular intervention.
A and B, Unenhanced CT scans show loss of gray matter–white matter differentiation (arrowheads) in left insular cortex and temporal lobe. Left middle cerebral ar-
tery (MCA) is hyperdense compared with basilar artery (arrow, A).
C, Left internal carotid artery injection image shows presence of clot (arrow) in internal carotid bifurcation and no flow visible in anterior and middle cerebral arteries.
D, Unsubtracted angiography shows microcatheter placed proximal to clot (arrow) before retrieval device was advanced.
E, Subsequent angiography shows persistent occlusion of MCA branches (arrow). Intraarterial tissue plasminogen activator (tPA) was infused through left MCA.
F, After infusion, tPA angiography shows opening of anterior division of left MCA and occlusion (arrow) of posterior division of left MCA.
guideline is that IV tPA must be given within 3 hours of stroke Solution to Question 13
onset. Option A is not the best response. Although administra- Maintaining adequate tissue oxygenation is critical in the
tion of tPA after the 3-hour window may benefit some pa- setting of acute stroke to prevent hypoxia and potential
tients, the interval between onset of symptoms and initiation worsening of brain damage. Patients with decreased con-
of thrombolysis remains the most critical factor in treatment, sciousness or brain stem dysfunction have the greatest risk of
because therapeutic efficacy decreases even within the 3-hour airway compromise. The prognosis of a patient who requires
window [12]. Clearly, “time is brain.” Whether diffusion–per- endotracheal intubation is generally poor; approximately
fusion mismatch can be used to better triage patients who ben- 50% of these patients die within 30 days of their stroke. Op-
efit from endovascular treatment beyond the 6-hour window is tion A is not best response.
yet to be determined in a large clinical trial. An extensive area of low attenuation on initial head CT
Streptokinase, used to treat acute ischemic stroke, is no lon- indicates widespread damage to the brain tissue. An “ear-
ger used because of unacceptably high rates of hemorrhage. It ly infarct sign” on unenhanced CT involving more than
should not be used. Option B is not the best response. Another one third of the territory of the middle cerebral infarction
thrombolytic agent, urokinase, has been occasionally used indicates a poor outcome. The presence of mass effect or
intraarterially to treat vertebral and basilar thrombosis in edema is also associated with an eightfold increase in the
some institutions up to 24 hours after symptom onset. risk of symptomatic hemorrhage [11]. Option B is not the
A randomized controlled trial from the International best response.
Stroke Trial showed that fewer recurrent ischemic strokes Hyperglycemia is associated with poor clinical outcomes,
occur in patients given heparin, but this improvement was presumably due to increased tissue acidosis secondary to an-
offset by an increase in hemorrhagic stroke [13]. Recent aerobic glycolysis and lactic acidosis. Hyperglycemia may af-
evidence does not support the routine use of heparin in pa- fect the blood–brain barrier and lead to brain edema. Hypo-
tients with acute stroke. Option C is not the best response. glycemia may cause focal neurologic signs and symptoms
The study evaluating the value of aspirin enrolled a large that mimic acute ischemic stroke. Hypoglycemia itself may
number of subjects. Aspirin was started between 12 and 24 aggravate neuronal ischemia. The prompt assessment of the
hours after stroke onset. The results showed that aspirin sig- serum glucose level and correction of the glucose level are
nificantly improved outcomes at 6 months, but the magnitude important. Option C is not the best response.
of the reduction was small. The early use of aspirin offers only Fever in the setting of acute ischemic stroke is associated with
modest benefit [14]. Option D is not the best response. a poor neurologic outcome secondary to increased metabolic de-
Intraarterial tPA and mechanical clot removal can be per- mands and enhanced release of neurotransmitters. Hypo
formed up to 6 hours after the onset of symptoms to an area thermia is not associated with poor clinical outcomes. In fact,
of blood clot via a microcatheter to an area of blood clot. The hypothermia has been reported to be neuroprotective in experi-
presence of intracranial hemorrhage, severely elevated blood mental models and small clinical trials. Hypothermia may delay
pressure, low platelet count, anticoagulation therapy, and depletion of the energy reserve, slow tissue acidosis, and slow
end-stage liver or kidney disease excludes the use of tPA. Op- calcium iron influx into cells. Option D is the best response.
tion E is the best response. Patients with acute ischemic stroke have an increased risk
Solution to Question 12 of developing myocardial infarction and cardiac arrhythmia.
Neurons die within a few minutes of oxygen deprivation. Patients with infarctions of the right hemisphere, particu-
Neuronal death occurs in areas of no blood flow within a few larly those involving the insula, may have an increased risk
minutes of stroke onset. Adjacent to such areas of neuronal of cardiac complications, presumably secondary to distur-
death is a region of hypoperfused, electronically silent tissues bances in autonomic nervous system function. The most
that receive barely enough blood flow to keep neurons alive. common arrhythmia associated with acute stroke is atrial fi-
This tissue is called the “ischemic penumbra.” A major goal brillation, which may be either the cause of stroke or a com-
of acute stroke management is resuscitation of the ischemic plication. Life-threatening arrhythmia is relatively uncom-
penumbra. Because neuronal death is time-dependent, it is mon, but sudden death may occur. Cardiac monitoring is
critical to intervene as early as possible. often required for at least first 24 hours after the onset of
Treatment of acute ischemic stroke with IV tPA has prov- stroke symptoms. Option E is not the best response.
en to be efficacious in clinical trials by reducing functional Conclusion
disability. However, only a fraction of patients with ischemic Stroke continues to have a devastating impact on public
stroke receive IV tPA. In a community-based observational health and is the third leading cause of death in the United
study of 13,440 patients, approximately 3% of all ischemic States. At least 700,000 new stroke cases occur every year.
stroke patients, and 10.4% of patients admitted within 3 Approximately 85% of all strokes are ischemic in nature. Be-
hours of stroke onset were treated with tPA [15]. Multicenter cause of the narrow therapeutic windows for treatment of
studies also report the rate of tPA use outside clinical trials acute ischemic stroke, timely evaluation, diagnosis, and
ranges from 1.6% to 6%. Option A is the best response. treatment are of paramount importance.
A B C
D E F
Fig. 5—38-year-old woman with severe headache, nausea, and vomiting. Patient had history of heart trans-
plantation.
A and B, Unenhanced CT scans of head shows vague area of low attenuation in right cerebellar hemisphere
and mild mass effect on right aspect of fourth ventricle (arrow, A). No hemorrhage, hydrocephalus, or midline
shift is present.
C–G, MR images of brain obtained 2 days after A and B. FLAIR images (C and D) show numerous foci of hy-
perintensity throughout cerebral and cerebellar hemispheres, predominantly at corticomedullary junction.
Some lesions are seen in basal ganglia as well as thalamus. Extent of disease is more than expected from CT,
indicating rapid progression of disease process. These numerous foci are markedly hyperintense on diffu-
sion-weighted images (E and F). Contrast-enhanced T1-weighted image (G) shows no area of abnormal en-
hancement on any lesions.
G
lodge inside medium-sized blood vessels, resulting in multi- ous foci of restricted diffusion can be seen in patients with
focal infarction, and then invade through the vascular walls, embolic infarction, brain abscesses, and metastases from high-
causing hemorrhagic transformation or direct extension ly cellular tumors [19]. Option B is not the best response.
into the parenchyma. This vasculopathy-mediated septic Neither involvement of the middle cerebellar peduncle
infarction has regional vulnerability to basal ganglia or nor leptomeningeal involvement is a typical finding for dis-
thalami, in addition to the corticomedullary junction. The seminated aspergillosis. Options C and D are not the best
predilection to basal ganglia and thalami indicates involve- responses.
ment of the lenticulostriate and thalamoperforating arter- Involvement of the paranasal sinuses is often seen in dia-
ies. Aspergillosis often destroys the internal elastic lamina betic patients who have angioinvasive mucormycosis. Mu-
of the cerebral arteries. Perforating vessels are the first ones cormycosis is a rare opportunistic infection caused by ubi
to lose their patency because of their narrow diameter. quitous fungi typically found in soil or dust. The route of
MRI characteristics of disseminated aspergillosis in- infection is usually rhinocerebral and is commonly seen in
volvement of the brain in 18 patients was reported by De- patients with uncontrolled diabetes, which is often associ-
Lone et al. [16] and others [17, 18]. Those authors reported ated with metabolic acidosis or ketoacidosis [20]. Mucormy-
that the typical MRI appearance is a predilection to basal cosis can spread from the paranasal sinuses to the brain in a
ganglia or thalami. Enhancement was minimal or absent. few days. Treatment should include aggressive débridement
Lack of enhancement is most likely related to the host’s and IV amphotericin B. Option E is not the best response.
immune capacity. Severely immunocompromised patients
have no or little immune capacity to react to an infectious Conclusion
organism to form capsule or inflammatory response; thus, Rapid progression, early ischemic manifestation, and
lack of enhancement may indicate poor prognosis and rapid predilection for the perforating arteries are characteristic
dissemination of angioinvasive aspergillosis. Option A is the features of disseminated aspergillosis infection in severely
best response. immunocompromised patients. Diagnosis should be made
Marked bright signal on diffusion-weighted images in this when clinical suspicion is high so that aggressive IV anti-
patient likely reflects infarction and cytotoxic edema. Numer- fungal therapy can be initiated.
QUESTION 17 QUESTION 19
What is the diagnosis given the imaging Which one of the following is a characteristic
abnormality and clinical presentations? clinical feature of Wernicke’s encephalopathy?
A. Creutzfeldt-Jakob disease. A. Learning disability.
B. Leigh disease. B. Rigidity and tremor.
C. Wernicke’s encephalopathy. C. Visual hallucination.
D. Maple syrup urine disease. D. Nystagmus and bilateral lateral rectus paralysis.
E. Wilson’s disease. E. Global ataxia.
A B
C D
Leigh disease is a mitochondrial disorder caused by pyru- are nystagmus, bilateral lateral rectus palsies, and conjugate
vate carboxylase deficiencies. It leads to necrotizing en- gaze palsies reflecting involvement of the oculomotor and ab-
cephalomyelopathy. Leigh disease often affects the putami- ducens nerves. Option D is the best response. Gait ataxia is
na bilaterally, other deep gray matter structures, and the believed to be due to focal midline degeneration of the supe-
brain stem [21]. Option B is not the best response. rior vermis, as opposed to global ataxia, a sign of cerebellar
Maple syrup urine disease results from severe inherited dysfunction. Option E is not the best response. Cerebellar
defects in branched-chain amino acids. Patients are unable testing with the finger-to-nose or heel-to-shin test may not
to catabolize branched-chain amino acids (leucine, isoleu- elicit any notable deficit. Vestibular dysfunction without
cine, and valine), which are increased in the blood and urine. hearing loss is also a common finding.
The primary therapy is a protein-restricted diet. MRI find- Rigidity and tremor as well as bradykinesia and postur-
ings are white matter involvement in the cerebellum, the al instability are common symptoms seen in patients with
periaqueductal gray matter along the dorsal midbrain, the Parkinson’s disease, not in patients with Wernicke’s enceph-
cerebral peduncle, and the basal ganglia and thalami. Ma- alopathy. Visual hallucination is associated with psychiat-
millary bodies are not involved. Patients with maple syrup ric disorders and drugs, particularly alcohol. Patients with
urine disease present as newborns or in infancy. Option D is schizophrenia often have visual and, more often, auditory
not the best response. hallucinations. Learning disability refers to a group of dis-
Wilson’s disease is an autosomal recessive disorder. The Wil- orders affecting academic and functional skills, including the
son’s disease gene is mapped to chromosome 13. The main fea- abilities to listen, speak, write, read, and organize informa-
ture is accumulation of copper in the tissues, predominantly tion. It is not specific for Wernicke’s encephalopathy. Thus,
in the cornea, brain, and liver. A suppressed level of cerulo- options A, B, and C are not the correct responses.
plasmin is observed in more than 80% of patients. Clinical
symptoms include dysarthria, dystonia, rigidity, and ataxia. Conclusion
MRI findings in Wilson’s disease are signal abnormality in the Wernicke’s encephalopathy is a severe medical emergency
lentiform nucleus and the thalami as well as tegmentum of that is often associated with malnutrition states. It is an un-
the midbrain, red nuclei, and substantia nigra. Periaqueduc- derdiagnosed disease that can be reversed or treated with IV
tal gray matter involvement has been reported in Wilson’s thiamin. Wernicke’s encephalopathy should be considered in
disease. Mamillary bodies are not normally abnormal in Wil- patients with chronic alcohol abuse and malnutrition or pro-
son’s disease. Option E is not the best response. longed vomiting along with acute confusion, ataxia, oculo-
motor abnormalities, and memory disturbance. Brain MRI
Solution to Question 18 should be ordered to assess changes in the patient’s mental
Wernicke’s encephalopathy is a neurologic disorder with status. It is important for radiologists to recognize this dis-
acute onset. It is caused by a thiamine deficiency due to ease so that appropriate treatment is initiated immediately.
poor oral intake in chronic alcoholics, food refusal in an-
orexia nervosa, or recurrent vomiting in pregnant patients. References
Approximately 50% of patients with Wernicke’s encepha 1. Brown E, Prager J, Lee HY, Ramsey RG. CNS complications of cocaine abuse:
lopathy are not alcoholic. This patient presented with 2 prevalence, pathophysiology, and neuroradiology. AJR 1992; 159:137–147
2. Chu CT, Gray L, Goldstein LB, Hulette CM. Diagnosis of intracranial vasculi-
weeks of nausea and vomiting. Other causes include chron- tis: a multi-disciplinary approach. J Neuropathol Exp Neurol 1998; 57:30–38
ic infection and a febrile status, pancreatitis, cancer, chron- 3. Grossman RI, Yousem DM. Vascular disease of the brain. In: Grossman RI,
ic dialysis, and prolonged parenteral hyperalimentation Yosem DM. Neuroradiology: the requisites, 2nd ed. St. Louis, MO: Mosby, 2003:
without a vitamin supplement [22]. Options A, B, C, and E P173–P241
4. Liang L, Korogi Y, Sugahara T, et al. Evaluation of the intracranial dural si-
are not the best responses. nuses with a 3D contrast-enhanced MR-RAGE sequence: prospective evalua-
Gastrectomy is often associated with vitamin B12 deficien- tion with 2D-TOF MR venography and digital subtraction angiography. AJNR
cies. In order for vitamin B12 to be absorbed from the small 2001; 22:481–492
bowel, it needs to be chemically linked to an intrinsic factor 5. Klingebiel R, Bauknecht HC, Bohner G, Kirsch R, Berger J, Masuhr F. Com-
parative evaluation of 2D-TOF and 3D elliptic centric contrast-enhanced MR
that is produced in the stomach. Gastrectomy leads to mal- venography in patients with presumptive cerebral venous and sinus thrombo-
absorption of vitamin B12, which results in pernicious ane- sis. Eur J Neurol 2007; 14:139–143
mia. Gastrectomy is least likely to be associated with Wer- 6. de Bruijn SF, Stam J, for the Cerebral Venous Sinus Thrombosis Study Group.
nicke’s encephalopathy. Option D is the best response. Randomized, placebo-controlled trial of anticoagulant treatment with low-
molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999;
30:484–488
Solution to Question 19 7. Mayberg MR, Batjer HB, Decey R, et al. Guidelines for the management of
The triad of encephalopathy, ataxic gait, and oculomotor aneurysmal subarachnoid hemorrhage. Circulation 1994; 90:2592–2605
8. Bederson JB, Awad IA, Wiebers DO, et al. Recommendations for the manage-
dysfunction is seen in only one third of patients with Wer-
ment of patients with unruptured intracranial aneurysms: a statement for
nicke’s encephalopathy. Ocular abnormalities are the hall- healthcare professionals from the Stroke Council of the American Heart As-
marks of Wernicke’s encephalopathy. The oculomotor signs sociation. Stroke 2000; 31:2742–2750
9. Campi A, Ramzi N, Molyneux AJ, et al. Retreatment of ruptured cerebral an- in patients with acute ischemic stroke and the risk of in-patients hospital mortality:
eurysms in patients randomized by coiling or clipping in the international sub- the German Stroke Registers Study Group. Stroke 2003; 34:1106–1113
arachnoid aneurysm trial (ISAT). Stroke 2007; 38:1538–1544 16. DeLone DR, Goldstein RA, Petermann G, et al. Disseminated aspergillosis
10. Hope JK, Wilson JL, Thomson FJ. Three-dimensional CT angiography in the involving the brain: distribution and imaging characteristics. AJNR 1999;
detection and characterization of intracranial berry aneurysms. AJNR 1996; 20:1597–1604
17:439–445 17. Gabelmann A, Klein S, Kern W, et al. Relevant imaging findings of cerebral
11. [No authors listed]. Tissue plasminogen activator for acute ischemic stroke. aspergillosis on MRI: a retrospective case-based study in immunocompro-
The National Institute of Neurologic Disorders and Stroke rt–PA Stroke Study mised patients. Eur J Neurol 2007; 14:548–555
Group. N Eng J Med 1995; 333:1581–1587 18. Tempkin AD, Sobonya RE, Seeger JF, Oh ES. Cerebral aspergillosis: radio-
12. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombi- logic and pathologic findings. RadioGraphics 2006; 26:1239–1242
nant tissue plasminogen activator for acute hemispheric stroke. The European 19. Hayashida Y, Hirai T, Morishita S, et al. Diffusion-weighted imaging of meta-
Corporative Acute Stroke Study (ECASS). JAMA 1995; 274:1017–1025 static brain tumors: comparison with histologic type and tumor cellularity.
13. International Stroke Trial Collaborative Group. The International Stroke Trial AJNR 2006; 27:1419–1425
(IST): a randomized trial of aspirin, subcutaneous heparin, both, or neither 20. Hopkins MA, Treloar DM. Mucormycosis in diabetes. Am J Crit Care 1997;
among 19435 patients with acute ischemic stroke. Lancet 1997; 349:1569–1581 6:363–367
14. [No authors listed]. CAST: randomised trial of early aspirin use in 20,000 pa- 21. Ho VC, Fitz CR, Chuang SH, Geyer CA. Bilateral basal ganglia lesions: pedi-
tients with acute ischemic stroke. CAST (Chinese Acute Stroke Trial) Collab- atric differential considerations. RadioGraphics 1993; 13:269–292
orative Group. Lancet 1997; 349:1641–1649 22. Bae SJ, Lee HK, Lee JH, Choi CG, Suh DC. Wernicke’s encephalopathy:
15. Heuschmann PU, Berger K, Misslwitz B, et al. Frequency of thrombolytic therapy atypical manifestation at MR imaging. AJNR 2001; 22:1480–1482